Artisan Partners
ARIA

Artisan Partners’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Artisan Partners’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,857,580
Closed -$52.6M – 380
2013
Q3 		$52.6M Sell
2,857,580
-6,940,433
-71% -$135M 0.1% 197
2013
Q2 		$171M Buy
+9,798,013
New +$174M 0.37% 104

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Artisan Partners's ARIA Position: Q4 2013 in Review

Artisan Partners sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2013, closing a stake of 2,857,580 shares — an estimated $52.6M sold.

Artisan Partners first reported a position in ARIA in Q2 2013 and held it in 2 quarters. The position peaked at $171M in Q2 2013. 166 funds tracked by Wall St. Rank hold ARIA as of Q4 2013.

  • Artisan Partners reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Artisan Partners sold 2,857,580 Ariad Pharmaceuticals Inc shares in Q4 2013, an estimated $52.6M.
  • Artisan Partners first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 2 quarters.
  • Artisan Partners's Ariad Pharmaceuticals Inc position peaked at $171M in Q2 2013.
  • 166 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2013.

Based on Artisan Partners's 13F filing for Q4 2013, filed 13 Feb 2014.